{
    "clinical_study": {
        "@rank": "147866", 
        "acronym": "ABSOLUTE-OS", 
        "arm_group": [
            {
                "arm_group_label": "Imotun capsule", 
                "arm_group_type": "Experimental", 
                "description": "Imotun capsule: 300.03mg/cap, orally, 1 capsule once a day during 24 weeks"
            }, 
            {
                "arm_group_label": "Imotun capsule placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Imotun capsule Placebo: Placebo 1 capsule once a day during 24 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate efficacy and safety of Imotun capsule in\n      osteoarthritis of the knee"
        }, 
        "brief_title": "The Study to Evaluate Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Osteoarthritis of the Knee", 
        "condition_browse": {
            "mesh_term": [
                "Osteoarthritis", 
                "Osteoarthritis, Knee"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a six-month, multicenter, randomized, double blind, parallel-group,placebo\n      controlled study. Patients take Imotun capsules or placebo once a day, between the meals.\n      Patients are allowed to take study drugs during the meal in the case of intolerant reflux of\n      oil smell from GI. If patients do not tolerate the pain, they are able to take Celecoxib as\n      a rescue medication  during 6 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female and male patients who aged 40 or more and agreement with written informed\n             consent\n\n          -  Patients with osteoarthritis according to ACR criteria lasted for the past 3 months\n             or more\n\n          -  Patients with Kellgren & Lawrence grade \u2161~\u2162 on radiographs\n\n          -  Patients with 40mm or higher 100mm Pain VAS on screening and baseline visit (based on\n             more painful knee)\n\n          -  Patients with Lequesne's index 5 or more on screening and baseline visit\n\n        Exclusion Criteria:\n\n          -  Patients who had taken SYSADOA within the past 3 months (Imotun, diacerein,\n             s-adenosyl-methionone, JOINS, glucosamine, chondroitin and any other cartilage\n             protective agents determined by investigator)\n\n          -  Patients who experienced cartilage surgery within the past 5 years or arthroscope\n             surgery within a year(one side or both)\n\n          -  Patients who were treated with joint space injection within the past 3 months\n\n          -  Patients who had taken NSAIDs including pain killers within 7 days (except, it is\n             acceptable to enroll the study if the patients have wash out periods at least 7 days\n             before randomization)\n\n          -  Patients with hypersensitivity or allergy to the study or rescue medicine or those\n             who have medical history.\n\n          -  Patients with severe liver, kidney or cardiac diseases who are not acceptable for the\n             study determined by investigator\n\n          -  Patients with active peptic ulcer or GI bleeding.\n\n          -  Pregnancy, nursing women or women of reproductive age who do not agree to the\n             contraception.\n\n          -  Patients with abuse of alcohol, illegal drugs or drug dependency\n\n          -  Patients who were treated with another investigational product within the past 4\n             weeks\n\n          -  All other patients who are not acceptable for the study determined by investigator"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "234", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01743287", 
            "org_study_id": "238KOA12F"
        }, 
        "intervention": [
            {
                "arm_group_label": "Imotun capsule", 
                "description": "Imotun capsule: Avocado-Soya Unsaponifiables 300.03mg/Cap, per oral, a capsule once a day during for 24 weeks", 
                "intervention_name": "Imotun capsule", 
                "intervention_type": "Drug", 
                "other_name": "Imotun capsule"
            }, 
            {
                "arm_group_label": "Imotun capsule placebo", 
                "description": "Imotun capsule placebo: per oral, a capsule a day during 24 weeks", 
                "intervention_name": "Imotun capsule placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "osteoarthritis of the knee", 
        "lastchanged_date": "September 2, 2013", 
        "location": [
            {
                "contact": {
                    "email": "oseschoi@chungbuk.ac.kr", 
                    "last_name": "Euisung Choi, Ph.D.", 
                    "phone": "+82 43 269 6072"
                }, 
                "facility": {
                    "address": {
                        "city": "Cheongju", 
                        "country": "Korea, Republic of", 
                        "state": "Chungcheonbuk-do"
                    }, 
                    "name": "Chungbuk National University Hospital"
                }, 
                "investigator": {
                    "last_name": "Euisung Choi, Ph.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "kcw8737@empal.com", 
                    "last_name": "Changwan Kim, Ph.D.", 
                    "phone": "+82 51 890 6129"
                }, 
                "facility": {
                    "address": {
                        "city": "Busan", 
                        "country": "Korea, Republic of", 
                        "zip": "633-165"
                    }, 
                    "name": "Inje University Busan Paik Hospital"
                }, 
                "investigator": {
                    "last_name": "Changwan Kim, Ph.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "hskyung@knu.ac.kr", 
                    "last_name": "Heesoo Kyung, phD", 
                    "phone": "+82 53 420 5636"
                }, 
                "facility": {
                    "address": {
                        "city": "Daegu", 
                        "country": "Korea, Republic of", 
                        "zip": "700-721"
                    }, 
                    "name": "Kyungpook National University Hospital"
                }, 
                "investigator": {
                    "last_name": "Heesoo Hyung, phD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "seonbell@yahoo.co.kr", 
                    "last_name": "Jeongkeun Seon, phD", 
                    "phone": "+82 61 379 8030"
                }, 
                "facility": {
                    "address": {
                        "city": "Hwasun", 
                        "country": "Korea, Republic of", 
                        "zip": "519-763"
                    }, 
                    "name": "Chonnam National University Hwasun hospital"
                }, 
                "investigator": {
                    "last_name": "Jeongkeun Seon, phD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jhlee55@jbnu.ac.kr", 
                    "last_name": "Joohong Lee, phD", 
                    "phone": "+82 63 250 1771"
                }, 
                "facility": {
                    "address": {
                        "city": "Jeonju", 
                        "country": "Korea, Republic of", 
                        "zip": "561-712"
                    }, 
                    "name": "Chonbuk National University Hospital"
                }, 
                "investigator": {
                    "last_name": "Joohong Lee, phD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "khc4h@unitel.co.kr", 
                    "last_name": "Heechun Kim, phD", 
                    "phone": "+82 31 780 5270"
                }, 
                "facility": {
                    "address": {
                        "city": "Seongnam", 
                        "country": "Korea, Republic of", 
                        "zip": "463-712"
                    }, 
                    "name": "Bundang CHA medical center"
                }, 
                "investigator": {
                    "last_name": "Heechun Kim, phD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "130-872"
                    }, 
                    "name": "KyungHee University Medical Center"
                }, 
                "status": "Completed"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "135-710"
                    }, 
                    "name": "Samsung Medical Center"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "leemc@snu.ac.kr", 
                    "last_name": "Myungchul Lee, phD", 
                    "phone": "+82 2 2072 3212"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "110-744"
                    }, 
                    "name": "Seoul National University Hospital"
                }, 
                "investigator": {
                    "last_name": "Myungchul Lee, phD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "sibin@amc.seoul.kr", 
                    "last_name": "Seongil Bin, phD", 
                    "phone": "+82 2 3010 3528"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "138-736"
                    }, 
                    "name": "ASAN Medical Center"
                }, 
                "investigator": {
                    "last_name": "Seongil Bin, phD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Six-month, Multi Center, Randomized, Double Blind, Parallel-group, Placebo Controlled Study to Evaluate Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee", 
        "other_outcome": [
            {
                "measure": "rate of adverse event", 
                "safety_issue": "Yes", 
                "time_frame": "up to 24 weeks"
            }, 
            {
                "measure": "laboratory test", 
                "safety_issue": "Yes", 
                "time_frame": "up to 24 weeks"
            }, 
            {
                "measure": "medication history", 
                "safety_issue": "Yes", 
                "time_frame": "up to 24 weeks"
            }
        ], 
        "overall_contact": {
            "email": "leemc@anu.ac.kr", 
            "last_name": "Myung Chul Lee, phD", 
            "phone": "+82 2 2072 3212"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Myung Chul Lee, phD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "assessment of the 100mm pain VAS", 
                "measure": "100mm pain VAS", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "measure": "change from baseline Lequesne's index score at 24 weeks", 
                "safety_issue": "No", 
                "time_frame": "baseline, 24 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01743287"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "change from baseline Lequesne's index score at 4 weeks", 
                "safety_issue": "No", 
                "time_frame": "baseline, 4 weeks"
            }, 
            {
                "measure": "change from baseline 100mm pain VAS at 4 weeks", 
                "safety_issue": "No", 
                "time_frame": "baseline, 4 weeks"
            }, 
            {
                "description": "assessment of 100mm pain VAS", 
                "measure": "100mm pain VAS", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "description": "global assessment by physician and patient", 
                "measure": "global assessment", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "measure": "administration days of the rescue medication", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "measure": "The rate of patients who consumed the rescue medication", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "measure": "change from baseline Lequesne's index score at 8 weeks", 
                "safety_issue": "No", 
                "time_frame": "baseline, 8 weeks"
            }, 
            {
                "measure": "change from baseline Lequesne's index score at 16 weeks", 
                "safety_issue": "No", 
                "time_frame": "baseline, 16 weeks"
            }, 
            {
                "measure": "change from baseline 100mm pain VAS at 8 weeks", 
                "safety_issue": "No", 
                "time_frame": "baseline, 8 weeks"
            }, 
            {
                "measure": "change from baseline 100mm pain VAS at 16 weeks", 
                "safety_issue": "No", 
                "time_frame": "baseline, 16 weeks"
            }, 
            {
                "measure": "change from baseline 100mm pain VAS at 24 weeks", 
                "safety_issue": "No", 
                "time_frame": "baseline, 24 weeks"
            }, 
            {
                "description": "assessment of 100mm pain VAS", 
                "measure": "100mm pain VAS", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "assessment of 100mm pain VAS", 
                "measure": "100mm pain VAS", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "global assessment by physician and patient", 
                "measure": "global assessment", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "global assessment by physician and patient", 
                "measure": "global assessment", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "global assessment by physician and patient", 
                "measure": "global assessment", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "measure": "dosing quantity of the rescue medication", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }
        ], 
        "source": "Chong Kun Dang Pharmaceutical", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chong Kun Dang Pharmaceutical", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}